Am J Hematol. 2010 Oct;85(10):797-9. doi: 10.1002/ajh.21807.
It is estimated that there are 100,000 people living with sickle-cell disease (SCD) in the United States [1]. The most common manifestation of SCD is vaso-occlusive crisis, which is characterized by intermittent, unexpected episodes of excruciating pain. As these episodes often come on suddenly, much of the care for these crises occurs within emergency departments (EDs). Several studies have examined ED use and costs for certain groups of patients with SCD [2-4]. For example, in 1997, Woods et al. [2] found that 85.7% of 7,202 hospital admissions for SCD in Illinois were for patients that came through the ED, and the total charges for sickle-cell admissions in Illinois were found to be $30 million a year. A recent study of healthcare use by children with SCD demonstrated that children insured by Medicaid had higher ED utilization than those with private insurance (57% vs.45%) [5]. The purpose of our study was to provide national level estimates of ED utilization by SCD patients, which have not previously been available.
据估计,美国有 10 万人患有镰状细胞病(SCD)[1]。SCD 最常见的表现是血管阻塞性危象,其特征是间歇性、突发的剧痛发作。由于这些发作常常突然发生,因此大部分对这些危象的护理都是在急诊部(ED)进行的。已有几项研究检查了特定 SCD 患者群体的 ED 使用情况和费用[2-4]。例如,1997 年,Woods 等人[2]发现,伊利诺伊州 7202 例 SCD 住院治疗中有 85.7%是通过 ED 入院的,伊利诺伊州 SCD 住院治疗的总费用为每年 3000 万美元。最近一项关于 SCD 儿童医疗保健使用情况的研究表明,医疗补助保险覆盖的儿童的 ED 利用率高于私人保险(57%对 45%)[5]。我们的研究目的是提供以前没有的全国范围内 SCD 患者 ED 使用情况的估计数。